Rigel Pharmaceuticals
RIGL
#6719
Rank
ยฃ0.38 B
Marketcap
ยฃ21.61
Share price
0.70%
Change (1 day)
231.68%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ0.12 Billion

According to Rigel Pharmaceuticals's latest financial reports the company's total liabilities are ยฃ0.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Rigel Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.11 B-6.34%
2022-12-31ยฃ0.12 B20.49%
2021-12-31ยฃ0.10 B81.13%
2020-12-31ยฃ56.01 M-21.65%
2019-12-31ยฃ71.49 M210.46%
2018-12-31ยฃ23.02 M68.56%
2017-12-31ยฃ13.66 M-27.04%
2016-12-31ยฃ18.72 M-31.25%
2015-12-31ยฃ27.23 M63.81%
2014-12-31ยฃ16.62 M54.03%
2013-12-31ยฃ10.79 M-16.7%
2012-12-31ยฃ12.95 M-3.88%
2011-12-31ยฃ13.48 M1.22%
2010-12-31ยฃ13.32 M-30.19%
2009-12-31ยฃ19.08 M-29.55%
2008-12-31ยฃ27.08 M60.1%
2007-12-31ยฃ16.91 M27.39%
2006-12-31ยฃ13.27 M-41.4%
2005-12-31ยฃ22.66 M64.05%
2004-12-31ยฃ13.81 M58.91%
2003-12-31ยฃ8.69 M-26.25%
2002-12-31ยฃ11.78 M-2.37%
2001-12-31ยฃ12.07 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ54.64 M-56.21%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ51.03 B 40,792.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ65.70 B 52,549.66%๐Ÿ‡บ๐Ÿ‡ธ USA